American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Algernon Health Inc. (AGNPF)

$0.29 +4.89% AGNPF · 15-min delayed

Public · AGNPF

AGNPFListed

About Algernon Health Inc.

GREY MATTERS HEALTH INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · AGNPF
Industry: Pharmaceuticals

Registry IDs

Ticker: AGNPF
SEC CIK: 1642178
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Algernon Health Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/algernon-health-inc/"><img src="https://americancompanies.com/badge/algernon-health-inc.svg" alt="Algernon Health Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Algernon Health Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Listed: AGNPF

$0.29 +4.89%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.23 $0.69

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Algernon Health Inc. (AGNPF) Stock Price

Trading 58% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Algernon Health Inc..

Write a review

Newsroom

News about Algernon Health Inc.

Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services GlobeNewswire Inc. · 2024-05-21 Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024 GlobeNewswire Inc. · 2024-04-24 Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024 GlobeNewswire Inc. · 2024-04-11

News & sentiment via Polygon.io

FAQ

Algernon Health Inc.: frequently asked questions

Is Algernon Health Inc. an American company?

Algernon Health Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Algernon Health Inc. publicly traded?

Yes — Algernon Health Inc. is a publicly traded company. Its stock trades under the ticker symbol AGNPF.

What does Algernon Health Inc. do?

Algernon Health Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore